SI3419673T1 - Genska terapija za zdravljenje bolezni retinalnih konusnih celic - Google Patents

Genska terapija za zdravljenje bolezni retinalnih konusnih celic

Info

Publication number
SI3419673T1
SI3419673T1 SI201730532T SI201730532T SI3419673T1 SI 3419673 T1 SI3419673 T1 SI 3419673T1 SI 201730532 T SI201730532 T SI 201730532T SI 201730532 T SI201730532 T SI 201730532T SI 3419673 T1 SI3419673 T1 SI 3419673T1
Authority
SI
Slovenia
Prior art keywords
disease
treatment
gene therapy
cone cells
retinal cone
Prior art date
Application number
SI201730532T
Other languages
English (en)
Inventor
Stylianos Michalakis
Martin Biel
Mathias Seeliger
Original Assignee
Eyeserv Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eyeserv Gmbh filed Critical Eyeserv Gmbh
Publication of SI3419673T1 publication Critical patent/SI3419673T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A61K48/0058Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A61K48/0066Manipulation of the nucleic acid to modify its expression pattern, e.g. enhance its duration of expression, achieved by the presence of particular introns in the delivered nucleic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0075Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14111Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/025Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a parvovirus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/008Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI201730532T 2016-02-23 2017-02-23 Genska terapija za zdravljenje bolezni retinalnih konusnih celic SI3419673T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/EP2016/053753 WO2017144080A1 (en) 2016-02-23 2016-02-23 Gene therapy for the treatment of a disease of retinal cone cells
PCT/EP2017/054229 WO2017144610A1 (en) 2016-02-23 2017-02-23 Gene therapy for the treatment of a disease of retinal cone cells
EP17707256.8A EP3419673B1 (en) 2016-02-23 2017-02-23 Gene therapy for the treatment of a disease of retinal cone cells

Publications (1)

Publication Number Publication Date
SI3419673T1 true SI3419673T1 (sl) 2021-03-31

Family

ID=55521674

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201730532T SI3419673T1 (sl) 2016-02-23 2017-02-23 Genska terapija za zdravljenje bolezni retinalnih konusnih celic

Country Status (12)

Country Link
US (1) US10849991B2 (sl)
EP (1) EP3419673B1 (sl)
JP (1) JP7005527B2 (sl)
CN (1) CN109310785A (sl)
AU (1) AU2017222948B2 (sl)
BR (1) BR112018017247A2 (sl)
CA (1) CA3015128A1 (sl)
DK (1) DK3419673T3 (sl)
ES (1) ES2835032T3 (sl)
IL (1) IL261295B2 (sl)
SI (1) SI3419673T1 (sl)
WO (2) WO2017144080A1 (sl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2661494B1 (en) * 2011-01-07 2019-06-12 Applied Genetic Technologies Corporation Promoters, expression cassettes and vectors for use treating achromatopsia and other diseases
GB201800546D0 (en) * 2018-01-12 2018-02-28 Ucl Business Plc Treatment
GB201900702D0 (en) * 2019-01-18 2019-03-06 Univ Bristol Therapy
WO2024033837A1 (en) * 2022-08-11 2024-02-15 Institute Of Molecular And Clinical Ophthalmology Basel (Iob) Human cone photoreceptor optogenetic constructs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2661494B1 (en) 2011-01-07 2019-06-12 Applied Genetic Technologies Corporation Promoters, expression cassettes and vectors for use treating achromatopsia and other diseases
US9375491B2 (en) * 2011-10-28 2016-06-28 University Of Florida Research Foundation, Inc. Chimeric promoter for cone photoreceptor targeted gene therapy
CN105764531A (zh) * 2013-05-16 2016-07-13 应用遗传科技公司 用于治疗色盲和其它疾病的启动子、表达盒、载体、药盒和方法

Also Published As

Publication number Publication date
AU2017222948A1 (en) 2018-08-30
CA3015128A1 (en) 2017-08-31
IL261295B1 (en) 2024-04-01
WO2017144610A1 (en) 2017-08-31
EP3419673A1 (en) 2019-01-02
AU2017222948B2 (en) 2021-05-27
WO2017144080A1 (en) 2017-08-31
IL261295A (en) 2018-10-31
DK3419673T3 (da) 2020-11-30
JP2019505238A (ja) 2019-02-28
US20180353619A1 (en) 2018-12-13
EP3419673B1 (en) 2020-09-02
CN109310785A (zh) 2019-02-05
ES2835032T3 (es) 2021-06-21
NZ745329A (en) 2024-03-22
IL261295B2 (en) 2024-08-01
US10849991B2 (en) 2020-12-01
BR112018017247A2 (pt) 2019-02-05
JP7005527B2 (ja) 2022-02-04

Similar Documents

Publication Publication Date Title
HRP20190117T1 (hr) iRNK TERAPIJA ZA LIJEČENJE BOLESTI OKA
EP3212233A4 (en) Combination therapy for treatment of disease
EP3188746A4 (en) Targeting capn9/capns2 activity as a therapeutic strategy for the treatment of myofibroblast differentiation and associated pathologies
PT3244931T (pt) Terapia génica da doença de fabry
EP3429605A4 (en) THERAPEUTIC AGENT FOR THE TREATMENT OF DISEASES, IN PARTICULAR DISEASES AFFECTING THE CENTRAL NERVOUS SYSTEM
GB201403260D0 (en) Treatment of retinal degeneration using gene therapy
EP3240612A4 (en) Methods of treating retinal diseases
HK1258518A1 (zh) 用於眼病的基因療法
IL268357A (en) Photoreceptor cells for the treatment of retinal diseases
IL261295A (en) Gene therapy for the treatment of retinal cone cell disease
HK1247963A1 (zh) 用於hiv的治療的基因療法及其用途
IL261292A (en) Gene therapy for the treatment of retinal degeneration
HK1253299A1 (zh) 一種通過基因治療治療眼疾病的改進方法
PL3129483T3 (pl) Terapia skojarzona do leczenia chorób autoimmunologicznych
EP3638316A4 (en) GENE THERAPY FOR EYE DISORDERS
IL268946A (en) Gene therapy for ocular disorders
GB201522416D0 (en) Wilson's disease gene therapy
EP3634986A4 (en) GENE THERAPY FOR EYE DISEASES
IL259381B (en) Miravegron for the treatment of retinal diseases
EP3154637A4 (en) Treatment of virus-based diseases of the skin
IL275613A (en) Gene therapy for eosinophilic disorders
GB201817469D0 (en) Gene therapy for retinal disease
SG11201703330YA (en) Iminosugars useful for the treatment of viral diseases
IL263837A (en) Treatment of ocular disease
AU2015904022A0 (en) Implants for the Treatment of Diseases and Disorders